FRANKLIN LAKES, N.J.,
April 23, 2018 /PRNewswire/ -- The
Board of Directors of BD (Becton, Dickinson and Company) (NYSE:
BDX) has declared a quarterly dividend of $0.75 per common share, payable on June 29, 2018 to holders of record on
June 8, 2018. The indicated
annual dividend rate is $3.00 per
share. In addition, the Board of Directors has declared a
quarterly dividend of $15.3125 per
share on the 6.125% mandatory convertible preferred stock, Series
A, payable on August 1, 2018 to
holders of record on July 15,
2018. This represents $0.7656
per depositary share (NYSE: BDXA).
About BD
BD is one of the largest global medical technology companies in the
world and is advancing the world of health by improving medical
discovery, diagnostics and the delivery of care. The company
supports the heroes on the frontlines of health care by developing
innovative technology, services and solutions that help advance
both clinical therapy for patients and clinical process for health
care providers. BD and its 65,000 employees have a passion and
commitment to help improve patient outcomes, improve the safety and
efficiency of clinicians' care delivery process, enable laboratory
scientists to better diagnose disease and advance researchers'
capabilities to develop the next generation of diagnostics and
therapeutics. BD has a presence in virtually every country and
partners with organizations around the world to address some of the
most challenging global health issues. By working in close
collaboration with customers, BD can help enhance outcomes, lower
costs, increase efficiencies, improve safety and expand access to
health care. In 2017, BD welcomed C. R. Bard and its products into
the BD family. For more information on BD, please visit bd.com.
Contact:
Kristen Cardillo, Corporate
Communications – 201-847-5657
Monique N. Dolecki, Investor
Relations – 201-847-5378
View original
content:http://www.prnewswire.com/news-releases/bd-board-declares-dividends-300634681.html
SOURCE BD (Becton, Dickinson and Company)